Impact pronostique de la prise en charge chirurgicale dans le corticosurrénalome malin à propos d’une série de 23 cas
Elie Bou Nasr(Hôpital Rangueil), É. Huyghe(Université Toulouse III - Paul Sabatier), Delphine Vezzosi(Université Toulouse III - Paul Sabatier), M. Soulié(Centre Hospitalier Universitaire de Toulouse), P. Carron(Hôpital Rangueil), Jean‐Baptiste Beauval, M. Roumiguié(Institut universitaire du cancer de Toulouse Oncopole), M. Thoulouzan(Hôpital Rangueil), J. Gas(Hôpital Rangueil), G. Crenn(Hôpital Rangueil), A. Bennet, P. Rischmann(Hospices Civils de Lyon), A. Gryn(Hôpital Rangueil), Thierry Almont(Université Toulouse III - Paul Sabatier)
Cited by 0
Related Papers
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
|The Lancet Oncology|2021|532
Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome
|New England Journal of Medicine|2014|434
Ketoconazole in Cushing's Disease: Is It Worth a Try?
|The Journal of Clinical Endocrinology & Metabolism|2014|288
Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study
|Annals of Oncology|2015|257
Sphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
|Cancer Research|2005|203